Grandfield & Dodd LLC increased Vertex Pharmaceuticals holdings by 1.4% in Q1, owning 9,115 shares.
Grandfield & Dodd LLC increased its holdings in Vertex Pharmaceuticals (NASDAQ:VRTX) by 1.4% in the first quarter, owning 9,115 shares after purchasing an additional 129 shares. Other institutional investors and hedge funds have also made changes to their positions in the company, including Vanguard Group Inc. and Capital World Investors. Vertex Pharmaceuticals shares reached a new 52-week high at $486.51.
July 11, 2024
5 Articles